Noticia the New York Times
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
JAMIESON WELLNESS INC. NOTICE of ANNUAL and SPECIAL MEETING of SHAREHOLDERS to Be Held on May 27, 2021 and MANAGEMENT INFORMATI
JAMIESON WELLNESS INC. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on May 27, 2021 and MANAGEMENT INFORMATION CIRCULAR dated March 11, 2021 JAMIESON WELLNESS INC. March 11, 2021 Dear shareholders of Jamieson Wellness Inc.: On behalf of the directors and management team of Jamieson Wellness Inc. (the “Company”), we are pleased to invite you to attend the Company’s annual and special shareholder meeting (the “Meeting”), taking place at 2:00 p.m. (Eastern Daylight Time) on May 27, 2021. Again this year, out of an abundance of caution, to proactively deal with the public health impact of the COVID-19 outbreak, and to mitigate the risks to the health and safety of our communities, shareholders, employees and other stakeholders, we will hold the Meeting in a virtual only format, which will be conducted via live audio webcast. At the Meeting, the holders of the common shares of the Company (“Shareholders”) will be asked to receive the financial statements for the year ended December 31, 2020 and the auditors’ report thereon, elect the directors for the ensuing year, re-appoint Ernst & Young LLP as the auditors of the Company, ratify By-Law No. 2 relating generally to the transaction of the business and affairs of the Company and consider the approval of an advisory “say on pay” resolution with respect to the Company’s approach to executive compensation. As a valued Shareholder, your views and involvement in the Company are important to us. At the Meeting you will have the opportunity to hear about the Company’s direction and plans for the coming year, ask questions and vote on the Meeting matters. -
The Dot Study
LIFESTYLE INTERVENTIONS FOR NON-ALCOHOLIC FATTY LIVER DISEASE Kirsten Coppell, Public Health Physician Senior Research Fellow, Department of Medicine, University of Otago; Training Programme Supervisor, NZCPHM Principles of Healthy Eating In 9 words….. • Eat less • Move more • Eat mostly fruits and vegetables For additional clarification – a 5 word modifier…… • Go easy on junk foods Nestle, Marion (2006). What to Eat. New York: North Point Press (Farrar, Straus and Giroux). ISBN 978-0-86547-738-4. HOW? How much does weight loss surgery cost? Weight Loss Surgery Fees Initial Consultation $280 Gastric Banding Surgery $18,500 Gastric Sleeve Surgery $20,750 Gastric Bypass Surgery $23,500 Additional Fees The Optifast pre-surgery meal replacement diet must be purchased separately from your local pharmacy. Other additional costs may include staying extra nights in hospital, extra theatre time, blood transfusion and/or x-rays. PLEASE NOTE: 99% of patients do not incur additional costs. Based on these costs……… To provide BS for 192,000 210,000 with BMI ≥40kg/m2 @ $20,000 per operation = $3,840,000,000 $4,200,000,000 $74.46M PHARMAC 2017 Year in Review 570,000 PHARMAC 2016 Year in Review The prevalence of overweight and obesity in NZ adults by age group, 2016/17. 100 Overweight Obesity 90 80 70 60 39.3 32.4 37.2 38.4 27.0 50 31.1 40 24.0 30 14.7 Proportion (%)Proportion 12.3 20 10 0 0-14 15-17 18-24 25-34 35-44 45-54 55-64 65-74 75+ Age Groups Ministry of Health. -
Women's Nutrition Connection June 2019 V22 N6
September 2016 Volume 19, Number 9 June 2019 Volume 22, Number 6 Beets and Other In the News .............................................. 2-3 • Diet drinks found to increase stroke risk “Super” Vegetables • Tomatoes’ health benefits differ by their skin color Tap into the healthy nutrients • Red raspberries may help blood in vegetable superfoods. sugar levels Healthy Eating ........................................... 2 uperfoods are aptly named because Demystifying today’s milk choices S their rich nutrients—including Getty | sagarmanis Images © Medical Nutrition .................................... 4 vitamins, minerals, antioxidants, and Choosing low-GI foods without disease-fighting phytochemicals—provide having to do the math numerous health benefits. They have been Beets contain betacyanin, which fights cancer, and the anti-inflammatory betaine. Supermarket Sleuth ............................. 5 linked with reducing inflammation and String cheese makes a healthy snack LDL (“bad”) cholesterol, and lowering Some of the most well-known and easy- your risk of a heart attack, stroke, to-find superfoods include beets, aspara- BodyWorks/ Moves of the Month .............................. 7 diabetes, and some cancers. gus, avocado, broccoli, carrots, and kale. Strengthen your pelvic floor muscles Superfoods are found in whole grains, Beets have high levels of potassium Ask Dr. Etingin ........................................... 8 protein, and fruit, but some of the most (an electrolyte which counters the effects • Is Lipozene a fad or does -
Weight Loss Drug Added to Diet and Exercise Improves Blood Sugar Control 17 June 2013
Weight loss drug added to diet and exercise improves blood sugar control 17 June 2013 The new weight loss drug lorcaserin (Belviq) the 3,185 patients in the placebo group did: an appears to improve blood sugar control in average of 12.8 pounds versus 5.6 pounds, the nondiabetic, overweight individuals, independent of study authors reported. However, even when the amount of weight they lose, a new study finds. lorcaserin-treated patients and placebo-treated The results will be presented Saturday at The patients lost the same amount of weight, those Endocrine Society's 95th Annual Meeting in San receiving lorcaserin had a greater average Francisco. decrease (improvement) in their hemoglobin A1c level than the other group did, Aronne said. Lorcaserin activates a serotonin receptor (5HT2C) Hemoglobin A1c is a measure of long-term in the brain believed to decrease appetite and glycemic (blood sugar) control. promote a sense of fullness, thus encouraging decreased food consumption, said the study's "More than just weight loss alone may explain the principal investigator, Louis Aronne, MD, professor significant improvement in glycemic control of clinical medicine at Weill Cornell Medical associated with lorcaserin," Aronne said. College, New York City. Fasting blood sugar levels also were better after "This analysis supports the possible role that the one year in the lorcaserin group, which had an drug's serotonin receptor activation may play in average decrease since the study started of 0.23 regulating glucose [blood sugar] metabolism," milligrams per deciliter (mg/dL), according to the Aronne said. abstract. In the placebo group, fasting blood sugar levels rose 0.60 mg/dL in the same period. -
10 Simple Daily Diet & Lifestyle Hacks for Weight Loss & Wellness 1. Eat
10 Simple Daily Diet & Lifestyle Hacks for Weight Loss & Wellness 1. Eat your carbs late in the day…and late on your plate Eat protein early in the day and punt your carbs to later in the day. This might be contrary to what you have been told. But a high healthy fat, low-carb breakfast with a moderate amount of protein will reduce your appetite for the rest of the day. Having carbs early in your day will increase your insulin levels and stimulate appetite making it harder to control your eating. In one study, young men were given instant oatmeal for breakfast one day, and on another day, they were given eggs. On the day they had the oatmeal, they ate 80 percent more than on the day they had eggs and were still hungry, even though they were eating more. So skip the bagels and cereal for breakfast, and eat your carbs later in the day when they will have less effect on your appetite. Order matters. Start each meal with the protein and vegetables and then have the carbohydrate. The worst thing you can do is to start a meal with bread. At any meal during which you plan to eat starchy food, hold off and eat it last. You will eat less if you fill up on vegetables and protein first. You will delay the response of insulin by changing the order in which the food is eaten. In another study, subjects were given bread to eat at the beginning of their meal (think bread basket before ordering your dinner). -
Weill Department of Medicine Annual Report 2016
Weill Department of Medicine Annual Report 2016 3 – 3 –– – 3 – Table of Contents Welcome from the Chairman 1 Leadership and Vice Chairs 2 Honors & Awards 10 Division Profiles 17 Residents & Fellows 49 Financial Report & Donors 53 Contacts 64 Fund For Medicine (FFM) Celebrates 25 years… What is the Fund For Medicine? n Launched in 1991, the Fund For Medicine supports endeavors in the Weill Department of Medicine that truly make 25a difference in delivering outstanding patient care, the education of physician-scientists, and the development of groundbreaking research. n Our physicians receive patients from all walks of life from the multicultural communities of New York City, as well as from the Nation and around-the-world. The cross-section of diseases seen in the Weill Department of Medicine is like none other in the world and covers the full spectrum. n Many of our patients face life-threatening diseases, from cancers and heart disease, to kidney disease, infectious diseases, and more. The Weill Department of Medicine is on the leading edge for life-saving therapies and treatments. n We are also providing much more than “hope” in underserved areas, in countries such as Brazil, Tanzania, and Haiti. Some of our top physician-scientists travel to these areas, having built critical patient care and research centers. And up-and-coming physician-scientists apply to our department in large numbers seeking the unparalleled training experience we offer. Cover images top to bottom: Dr. Shing-Chiu Wong, Division of Cardiology; Dr. David Artis Lab, Division of Gastroenterology and Hepatology; Dr. Lia Logio with residents in training. -
Management of Obesity in Adults S1 Introduction Stephen A
This supplement was sponsored by Primary SUPPLEMENT TO Care Education Consortium and Primary Care Metabolic Group and is supported by funding from Novo Nordisk Inc. It was edited and peer reviewed by The Journal of Family Practice. Copyright © 2014 Frontline Medical Communications Inc. ® WWW.PCECONSORTIUM.ORG WWW.PCMG-US.ORG VOL 63, NO 7 | JULY 2014 | www.jfponline.com Management of Obesity in Adults S1 Introduction Stephen A. Brunton, MD, FAAFP S3 Pathophysiology, Epidemiology, and Assessment of Obesity in Adults Neil S. Skolnik, MD; and Donna H. Ryan, MD S11 Tips for Communicating With Overweight and Obese Patients Carlos Campos, MD, MPH, CDE S15 Principles and Nonpharmacologic Management of Obesity in Adults Robert F. Kushner, MD, MS, FACP; and Denise K. Sur, MD S21 The Pharmacological and Surgical Management of Adults With Obesity Donna H. Ryan, MD S27 Evolving Directions in Obesity Management Louis J. Aronne, MD, FACP Management of Obesity in Adults FACULTY Meda Pharmaceuticals; Novo Nordisk, Inc.; and Teva Pharmaceuticals USA, Inc. Stephen A. Brunton, MD, FAAFP Adjunct Clinical Professor Neil S. Skolnik, MD discloses that he is on the advisory boards for Department of Family Medicine AstraZeneca, Boehringer Ingelheim GmbH; Eli Lilly and Company; University of North Carolina Sucampo Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; and Chapel Hill, North Carolina VIVUS, Inc. He is on the speakers’ bureau for AstraZeneca. Executive Vice President for Education Primary Care Education Consortium Donna H. Ryan, MD discloses that she is on the advisory boards for Charlotte, North Carolina Eisai Inc.; Janssen Pharmaceuticals, Inc.; Novo Nordisk, Inc.; Takeda Neil S. Skolnik, MD Pharmaceuticals U.S.A., Inc.; and VIVUS, Inc. -
Recombinant Human Leptin Does Not Alter Gut Hormone Levels After Gastric Bypass but May Attenuate Sweet Cravings
Hindawi Publishing Corporation International Journal of Endocrinology Volume 2014, Article ID 120286, 8 pages http://dx.doi.org/10.1155/2014/120286 Clinical Study Recombinant Human Leptin Does Not Alter Gut Hormone Levels after Gastric Bypass but May Attenuate Sweet Cravings Rushika Conroy,1,2 Gerardo Febres,3 Donald J. McMahon,3 Michael O. Thorner,4 Bruce D. Gaylinn,4 Irene Conwell,3 Louis Aronne,5 and Judith Korner3 1 DivisionofPediatricEndocrinology,ColumbiaUniversityMedicalCenter,NewYork,NY10032,USA 2 Division of Pediatric Endocrinology, Baystate Medical Center, Springfield, MA 01199, USA 3 Division of Endocrinology, Columbia University Medical Center, New York, NY 10032, USA 4 Division of Medicine, University of Virginia Medical Center, Charlottesville, VA 22902, USA 5 Division of Medicine, Cornell University Medical Center, New York, NY 10021, USA Correspondence should be addressed to Judith Korner; [email protected] Received 7 November 2013; Accepted 19 February 2014; Published 20 March 2014 Academic Editor: Yi-Hao Yu Copyright © 2014 Rushika Conroy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Bariatric surgery improves glucose homeostasis and alters gut hormones partly independent of weight loss. Leptin plays a role in these processes; levels are decreased following bariatric surgery, creating a relative leptin insufficiency. We previously showed that leptin administration in a weight-reduced state after Roux-en-Y gastric bypass (RYGB) caused no further weight loss. Here, we discuss the impact of leptin administration on gut hormones, glucostasis, and appetite. Weight stable women after RYGB were randomized to receive placebo or recombinant human metreleptin (0.05 mg/kg twice daily). -
Effect of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Treated with Metformin
Clinical Care/Education/Nutrition ORIGINAL ARTICLE Effect of Orlistat in Overweight and Obese Patients With Type 2 Diabetes Treated With Metformin JOHN M. MILES, MD MICHAEL DOYLE, MD glycemic cardiovascular risk factors (7– LAWRENCE LEITER, MD JOHN FOREYT, PHD 9). Metformin produces minimal weight PRISCILLA HOLLANDER, MD, PHD LOUIS ARONNE, MD gain or slight weight loss, presumably THOMAS WADDEN, PHD SAMUEL KLEIN, MD by reducing energy intake (10–12). In JAMES W. ANDERSON, MD addition, data from the U.K. Prospective Diabetes Study (UKPDS) suggest that metformin therapy decreases the inci- dence of adverse cardiovascular events OBJECTIVE — The purpose of this study was to assess the effect of orlistat, a gastrointestinal (13). Therefore, metformin may be the lipase inhibitor, on body weight, glycemic control, and cardiovascular risk factors in metformin- preferred choice for oral therapy in over- treated type 2 diabetic patients. weight or obese type 2 diabetic patients. RESEARCH DESIGN AND METHODS — A 1-year multicenter, randomized, double- The limited long-term success of non- blind, placebo-controlled trial of 120 mg orlistat t.i.d. (n ϭ 249) or placebo (n ϭ 254) combined pharmacologic weight loss interventions with a reduced-calorie diet was conducted in overweight and obese patients with suboptimal in patients with type 2 diabetes has in- control of type 2 diabetes. creased interest in adjunctive antiobesity pharmacotherapy. In randomized- RESULTS — After 1 year of treatment, mean (ϮSE) weight loss was greater in the orlistat than controlled trials of currently approved Ϫ Ϯ Ϫ Ϯ Ͻ in the placebo group ( 4.6 0.3% vs. -
Understanding Gluten Avoidance and Point-Of-Decision Prompts to Increase Fiber Consumption
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Dissertations, Theses, & Student Research in Food Science and Technology Food Science and Technology Department Summer 7-30-2020 CONSUMER ATTITUDES, KNOWLEDGE, AND BEHAVIOR: UNDERSTANDING GLUTEN AVOIDANCE AND POINT-OF-DECISION PROMPTS TO INCREASE FIBER CONSUMPTION Kristina Arslain University of Nebraska - Lincoln, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/foodscidiss Part of the Food Science Commons Arslain, Kristina, "CONSUMER ATTITUDES, KNOWLEDGE, AND BEHAVIOR: UNDERSTANDING GLUTEN AVOIDANCE AND POINT-OF-DECISION PROMPTS TO INCREASE FIBER CONSUMPTION" (2020). Dissertations, Theses, & Student Research in Food Science and Technology. 110. https://digitalcommons.unl.edu/foodscidiss/110 This Article is brought to you for free and open access by the Food Science and Technology Department at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Dissertations, Theses, & Student Research in Food Science and Technology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. CONSUMER ATTITUDES, KNOWLEDGE, AND BEHAVIOR: UNDERSTANDING GLUTEN AVOIDANCE AND POINT-OF-DECISION PROMPTS TO INCREASE FIBER CONSUMPTION by Kristina B. Arslain A THESIS Presented to the Faculty of The Graduate College of the University of Nebraska In Partial Fulfillment of Requirements For the Degree of Master of Science Major: Food Science and Technology Under the Supervision of Professors Devin J. Rose and Christopher R. Gustafson Lincoln, Nebraska July, 2020 CONSUMER ATTITUDES, KNOWLEDGE, AND BEHAVIOR: UNDERSTANDING GLUTEN AVOIDANCE AND POINT-OF-DECISION PROMPTS TO INCREASE FIBER CONSUMPTION Kristina B. Arslain, M.S. University of Nebraska, 2020 Advisors: Devin J. Rose and Christopher R. Gustafson Understanding consumer food behavior is important for creating effective health programs and policies that address obesity. -
The Role of Diet Type, Dieting Strategies, Bmi, And
LOSING WEIGHT AND EATING DISORDER RISK: THE ROLE OF DIET TYPE, DIETING STRATEGIES, BMI, AND PSYCHOLOGICAL FACTORS IN ACHIEVING WEIGHT LOSS AND INCREASING EATING DISORDER RISK By OLESYA VLADIMIROVNA MIKHEEVA A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY WASHINGTON STATE UNIVERSITY Department of Psychology JULY 2019 © Copyright by OLESYA VLADIMIROVNA MIKHEEVA, 2019 All Rights Reserved © Copyright by OLESYA VLADIMIROVNA MIKHEEVA, 2019 All Rights Reserved To the Faculty of Washington State University: The members of the Committee appointed to examine the dissertation of OLESYA VLADIMIROVNA MIKHEEVA find it satisfactory and recommend that it be accepted. Sarah Tragesser, Ph.D., Chair Paul Kwon, Ph.D. Paul Strand, Ph.D. ii ACKNOWLEDGMENT I would like to thank Sarah Tragesser for her support and education throughout my graduate training and for her guidance in creating this project. I also extend my thanks to Eric Desmarais for his assistance as a statistics consultant and his support throughout this project. Finally, I thank Jacob Mussman for his constant support throughout this process. iii LOSING WEIGHT AND EATING DISORDER RISK: THE ROLE OF DIET TYPE, DIETING STRATEGIES, BMI, AND PSYCHOLOGICAL FACTORS IN ACHIEVING WEIGHT LOSS AND INCREASING EATING DISORDER RISK Abstract by Olesya Vladimirovna Mikheeva, Ph.D. Washington State University July 2019 Chair: Sarah Tragesser Although research has investigated various weight loss strategies among those with obesity, and the link between a desire to lose weight and eating disorders is well known, research focused on understanding how dieting attempts increase eating disorder risk is almost completely lacking. The present study was the first to examine these constructs simultaneously to determine how psychological factors, dieting strategies, type of diet, and BMI contribute to weight loss and/or eating disorder risk. -
Role of Leptin in Energy Homeostasis in Humans
M ROSENBAUM and R L LEIBEL Leptin and human energy 223:1 T83–T96 Thematic Review homeostasis 20 YEARS OF LEPTIN Role of leptin in energy homeostasis in humans Michael Rosenbaum and Rudolph L Leibel Correspondence should be addressed Division of Molecular Genetics, Departments of Pediatrics and Medicine, College of Physicians and Surgeons, to M Rosenbaum Columbia University, Russ Berrie Medical Science Pavilion, 6th Floor, 1150 St Nicholas Avenue, New York, Email New York 10032, USA [email protected] Abstract The hyperphagia, low sympathetic nervous system tone, and decreased circulating concen- Key Words trations of bioactive thyroid hormones that are common to states of congenital leptin deficiency " leptin and hypoleptinemia following and during weight loss suggest that the major physiological " metabolism function of leptin is to signal states of negative energy balance and decreased energy stores. " energy In weight-reduced humans, these phenotypes together with pronounced hypometabolism and " obesity increased parasympathetic nervous system tone create the optimal circumstance for weight regain. Based on the weight loss induced by leptin administration in states of leptin deficiency (obese) and observed similarity of phenotypes in states of congenital and dietary-induced states of hypoleptinemia (reduced obese), it has been suggested that exogenous leptin could potentially be useful in initiating, promoting, and sustaining weight reduction. However, the Journal of Endocrinology responses of human beings to exogenous leptin administration are dependent not only on extant energy stores but also on energy balance. Leptin administration to humans at usual weight has little, if any, effect on body weight while leptin administration during weight loss mitigates hunger, especially if given in supraphysiological doses during severe caloric restriction.